Gradient Capital Advisors LLC raised its holdings in iShares iBonds Dec 2032 Term Corporate ETF (NYSEARCA:IBDX – Free Report) by 7.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,536 shares of the company’s stock after buying an additional 2,382 shares during the quarter. Gradient Capital Advisors LLC owned approximately 0.13% of iShares iBonds Dec 2032 Term Corporate ETF worth $800,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of IBDX. Integrated Wealth Concepts LLC boosted its position in shares of iShares iBonds Dec 2032 Term Corporate ETF by 6.4% in the third quarter. Integrated Wealth Concepts LLC now owns 15,518 shares of the company’s stock worth $399,000 after acquiring an additional 932 shares during the last quarter. Confluence Investment Management LLC raised its stake in iShares iBonds Dec 2032 Term Corporate ETF by 0.4% during the fourth quarter. Confluence Investment Management LLC now owns 411,172 shares of the company’s stock worth $10,107,000 after purchasing an additional 1,809 shares during the period. First United Bank & Trust acquired a new position in shares of iShares iBonds Dec 2032 Term Corporate ETF in the 4th quarter valued at $47,000. Peloton Wealth Strategists grew its stake in shares of iShares iBonds Dec 2032 Term Corporate ETF by 7.9% during the 3rd quarter. Peloton Wealth Strategists now owns 41,000 shares of the company’s stock valued at $1,054,000 after buying an additional 3,000 shares during the period. Finally, Captrust Financial Advisors grew its stake in shares of iShares iBonds Dec 2032 Term Corporate ETF by 14.9% during the 3rd quarter. Captrust Financial Advisors now owns 30,683 shares of the company’s stock valued at $789,000 after buying an additional 3,977 shares during the period.
iShares iBonds Dec 2032 Term Corporate ETF Stock Down 0.2 %
Shares of IBDX opened at $24.63 on Wednesday. iShares iBonds Dec 2032 Term Corporate ETF has a twelve month low of $23.93 and a twelve month high of $25.89. The stock’s fifty day simple moving average is $24.68 and its 200 day simple moving average is $25.07.
iShares iBonds Dec 2032 Term Corporate ETF Profile
The iShares iBonds Dec 2032 Term Corporate ETF (IBDX) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg index of USD-denominated, investment grade corporate bonds maturing between January 1, 2032 and December 15, 2032. IBDX was launched on Jun 28, 2022 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares iBonds Dec 2032 Term Corporate ETF
- How to Invest in the Best Canadian StocksÂ
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Business Services Stocks Investing
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- How to Use the MarketBeat Excel Dividend Calculator
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for iShares iBonds Dec 2032 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2032 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.